Description

Morphine Related Compound B Cii (20 Mg) (Pseudomorphine) is a high-purity analytical reference standard, specifically identified as Pseudomorphine, a dimeric oxidation product of morphine. This compound is critical for pharmaceutical research, forensic analysis, and quality control laboratories requiring precise calibration and method validation. It is primarily utilized by analytical chemists, forensic toxicologists, and regulatory scientists in pharmaceutical development and drug testing programs to ensure accurate identification and quantification of morphine and its related substances.

Application

• Pharmaceutical Impurity Profiling and Method Development: Serves as a certified reference material (CRM) for the identification and quantification of Pseudomorphine as a specified impurity in morphine active pharmaceutical ingredient (API) and finished drug products according to ICH Q3B guidelines.
• Forensic Toxicology and Drug Testing: Used as a critical calibrant and control in confirmatory analytical techniques (e.g., LC-MS/MS, GC-MS) for the accurate detection of morphine metabolites and degradation products in biological matrices.
• Stability Studies and Degradation Pathway Analysis: Employed in forced degradation studies to understand the oxidative degradation pathways of morphine, aiding in the formulation of stable pharmaceutical products.
• Academic and Clinical Research: Supports pharmacological and metabolic studies investigating the behavior, activity, and analysis of morphine and its transformation products.
• Quality Control Laboratory Calibration: Provides a traceable standard for routine HPLC or UPLC assays in pharmaceutical QC labs to monitor impurity levels and ensure batch-to-batch consistency.
• Regulatory Compliance and Documentation: Essential for generating data to support regulatory filings (e.g., with FDA, EMA) by providing evidence of robust analytical methods for impurity control.

Basic Information

Product Name	Morphine Related Compound B Cii (20 Mg) (Pseudomorphine)
CAS No.	6472-73-7
Molecular Formula	C34H36N2O6
Molecular Weight	568.66 g/mol
Synonyms	Pseudomorphine; Dehydromorphine; Morphine Dimer; Morphine Oxidation Dimer; 2,2'-Bimorphine; Morphine Related Compound B; Morphine Impurity B; (5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol Dimer
EINECS	Contact for details

Quality Control

Every batch of Morphine Related Compound B (Pseudomorphine) is manufactured and controlled to meet the exacting standards required for analytical reference materials. Our products undergo rigorous quality testing, including identity confirmation by spectroscopic methods and purity assessment by chromatographic techniques, to ensure compliance with industry standards. Certificates of Analysis (COA) containing batch-specific data for identity, purity (HPLC assay), and related substances are available upon request.

Storage

Preserve in the original tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or Certificate of Analysis. Keep the container tightly sealed in a dry and well-ventilated place. This product is light-sensitive (store away from light).

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any individual impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.